Atlas Trials

RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma

Clinical trial NCT05028439 · COMPLETED

Trial details

NCT number
NCT05028439
Sponsor
First People's Hospital of Hangzhou
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cholangiocarcinoma
Start date
2020-01-01
Primary completion
2022-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.